Family history of gastric cancer: Should we test and treat for Helicobacter pylori?

Journal of Clinical Gastroenterology

Volumn 36, Issue 3, 2003, Pages 204-208

  Niv, Yaron ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Atrophy; Gastric cancer; Helicobacter pylori; Intestinal metaplasia; Oncology; Premalignant state

Indexed keywords

ATROPHY; BACTERIAL COLONIZATION; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; COST EFFECTIVENESS ANALYSIS; DNA FINGERPRINTING; ERADICATION THERAPY; FAMILY HISTORY; GENETICS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HIGH RISK POPULATION; HUMAN; INTESTINE METAPLASIA; JAPAN; MORTALITY; ONCOLOGY; PRECANCER; PRIMARY PREVENTION; PRIORITY JOURNAL; RELATIVE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SECONDARY PREVENTION; STOMACH CANCER; WESTERN HEMISPHERE;

HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; RISK ASSESSMENT; RISK FACTORS; STOMACH NEOPLASMS;

EID: 0037369148     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-200303000-00004     Document Type: Review

References (74)

1. Williams MP, Pounder RE. Helicobacter pylori: From the benign to the malignant. Am J Gastroenterol 1999;94(Suppl):S11-6.
2. Kuipers EJ. Relationship between Helicobacter pylori, atrophic gastritis and gastric cancer. Aliment Pharmacol Ther 1998;12(Suppl 1):25-36.
3. The EUROGAST Study Group. An international association between Helicobacter pylori infection and gastric cancer. Lancet 1993;341:1359-62.
4. Forman D, Newell DG, Fullerton F, et al. Association between infection with Helicobacter pylori and risk of gastric cancer: Evidence from a prospective investigation. BMJ 1991;302:1302-5.
5. Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991:325:1127-31.
6. Nomura A, Stemmermann GN. Helicobacter pylori and gastric cancer. J Gastroenterol Hepatol 1993;8:294-303.
7. Forman D, Webb P, Parsonnet J. H. pylori and gastric cancer. Lancet 1994;343:243-4.
8. Huang JQ, Sridhar S, Chen Y, et al. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 1998;114:1169-79.
9. Eslick GD, Lim LLY, Byles JE, et al. Association of Helicobacter pylori infection with gastric carcinoma: A meta-analysis. Am J Gastroenterol 1999;94:2373-9.
10. Fuchs CS, Mayer RJ. Gastric carcinoma. N Engl J Med 1995;333:32-41.
11. Watanabe T, Tada M, Nagai H, et al. Helicobacter pylori infection induces gastric cancer in Mongolian gerbils. Gastroenterology 1998;115:642-8.
12. Peek RM, Wirth HP, Moss SF, et al. Helicobacter pylori alters gastric epithelial cell cycle events and gastrin secretion in Mongolian gerbils. Gastroenterology 2000;118:48-59.
13. Infection with Helicobacter pylori. In: IARC Monographs on the Evaluation of the Carcinogenic Risks to Humans, Vol. 61. Schistosomes, liver flukes and Helicobacter pylori. Lion, France: International Agency for research on Cancer, 1994:177-241.
14. Malfertheiner P, Megraud F, O'Morain C, et al. Current European concepts in the management of Helicobacter pylori infection: The Maastricht Consensus Report. The European Helicobacter pylori Study Group (EHPSG). Eur J Gastroenterol Hepatol 1997;9:1-2.
15. Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal tumor development. N Engl J Med 1988;319:525-32.
16. Correa P, Haenszel W, Cuello C, et al. A model for gastric cancer epidemiology. Lancet 1975;2:58-9.
17. Kuipers EJ, Uyterlinde AM, Pena AS, et al. Long term sequelae of Helicobacter pylori gastritis. Lancet 1995;345:1525-8.
18. Luk GD. Tumors of the stomach. In: Sleisenger MD, Feldman M, eds. Gastrointestinal and Liver Disease, 6th ed. Philadelphia: WB Saunders, 1998:733-57.
19. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784-9.
20. Brenes F, Ruiz B, Correa P, et al. Helicobacter pylori causes heperproliferation of the gastric epithelium: Pre and post-eradication indices of proliferating cell nuclear antigen. Am J Gastroenterol 1993;88:1870-5.
21. Correa P, Ruiz B, Shi TY, et al. Helicobacter pylori and nuclear organizer regions in the gastric antral mucosa. Am J Clin Pathol 1994;101:656-60.
22. Lynch DA, Mapstone NP, Clarke AM, et al. Cell proliferation in the gastric corpus in Helicobacter pylori associated gastritis and after gastric resection. Gut 1995;36:351-3.
23. Cahill RJ, Xia H, Kilgallen C, et al. Effect of eradication of Helicobacter pylori infection on gastric epithelial cell proliferation. Dig Dis Sci 1995;40:1627-31.
24. Fan XG, Kelleher D, Fan XJ, et al. Helicobacter pylori increases proliferation of gastric epithelial cells. Gut 1996;38:19-22.
25. Rokkas T, Papatheodorou G, Karameris A, et al. Helicobacter pylori infection and gastric juice vitamin C levels. Impact of eradication. Dig Dis Sci 1995;40:615-21.
26. Ravizza M, Giacobbe U, Suriani R, et al. Intestinal metaplasia in the stomach after eradication in Helicobacter pylori-positive patients: Three-year follow-up. Gut 1999;45:09/09.
27. Correa P, Fontham, Ruiz B, et al. Chemoprevention of gastric dysplasia effect of anti-Helicobacter pylori treatment and antioxidant supplementation. Gut 1999;45:06/05.
28. Alila J, Niemala S, Kerola T, et al. Cell proliferation and glandular atrophy in lymphocytic gastritis: The effect of H. pylori treatment. Gut 1999;45:06/02.
29. Ravizza MG, Suriani R, Cappelleti F, et al. Does Helicobacter pylori eradication modify intestinal metaplasia evolution in the stomach? [abstract]. Gastroenterology 2000;118:A751.
30. Sato R, Fujioka T, Murakami K, et al. Cure of Helicobacter pylori infection improves gastric atrophy without regression of intestinal metaplasia [abstract]. Gastroenterology 2000;118:A751.
31. Tepes B, Kovacic B, Zaletel LK, et al. Two to four year histological followup of gastric mucosa after Helicobacter pylori eradication. J Pathol 1999;188:24-9.
32. Satoh K, Kimura K, Takimoto T, et al. A follow up study of atrophic gastritis and intestinal metaplasia after eradication of Helicobacter pylori. Helicobacter 1998;3:236-40.
33. Yu J, Leung WK, Go MY, et al. Effects of H. pylori eradication on the expression of cyclin D2 and p27 in gastric intestinal metaplasia [abstract]. Gastroenterology 2000;118:A764.
34. Uemura N, Okamoto S, Mukai T, et al. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomarkers Prev 1997;6:639-42.
35. Uemura N, Okamoto S, Yamamoto S, et al. Effects of Helicobacter pylori eradication on the background gastric mucosa in the patients after endoscopic mucosal resection of early gastric cancer [abstract]. Gastroenterology 2000;118:A502.
36. Faller G, Winter M, Steininger H, et al. Decrease of antigastric antibodies in Helicobacter pylori gastritis after cure of infection. Pathol Res Pract 1999;195:243-6.
37. Gotoda T, Saito D, Kondo H, et al. Endoscopic and histological reversibility of gastric adenoma after eradication of Helicobacter pylori. J Gastroenterol 1999;34(Suppl 11):91-6.
38. Rugge M, Farinati F, Baffa R, et al. Interdisciplinary group on gastric epithelial dysplasia. Gastric epithelial dysplasia in the natural history of gastric cancer: A multicenter prospective follow-up study. Gastroenterology 1994;107:1288-96.
39. Farinati F, Foschia F, Di Mario F, et al. H. pylori eradication and gastric precancerous lesions. Gastroenterology 1998;115:512-4.
40. Rugge M, Cassaro M, Leo G, et al. Helicobacter and gastric cancer: both primary and secondary prevention measures are required. Arch Intern Med 1999;159:2483-4.
41. La Vecchia C, Negri E, Franceschi S, et al. Family history and the risk of stomach and colorectal cancer. Cancer 1992;70:50-5.
42. Bresalier RS, Kim YS. Malignant neoplasms of the large intestine. In: Sleisenger MD, Feldman M, eds. Gastrointestinal and Liver Disease, 6th ed. Philadelphia: WB Saunders, 1998:1906-42.
43. Peterson WL, Graham DY. Helicobacter pylori. In: Sleisenger MD, Feldman M, eds. Gastrointestinal and Liver Disease, 6th ed. Philadelphia: WB Saunders, 1998:604-19.
44. Covacci A, Telford JL, Del Giudice G, et al. Helicobacter pylori virulence and genetic geography. Science 1999;284:1328-33.
45. Bamford KB, Bickley J, Collins JSA, et al. Helicobacter pylori: Comparison of DNA fingerprints provides evidence for intrafamilial infection. Gut 1993;34:1348-50.
46. Brenner H, Bode G, Boeing H. Helicobacter pylori infection among offspring of patients with stomach cancer. Gastroenterology 2000;118:31-5.
47. Parsonnet J. When heredity is infectious. Gastroenterology 2000;118:222-7.
48. Wong BC, Lam SK, Ching CK, et al. Seroprevalence of cytotoxin-associated gene A positive Helicobacter pylori strains in Changle, an area with high prevalence of gastric cancer in south China. Aliment Pharmacol Ther 1999;13:1295-302.
49. Brenner H, Arndt V, Sturmer T, et al. Individual and joint contribution of family history and Helicobacter pylori infection to the risk of gastric carcinoma. Cancer 2000;88:274-9.
50. Maeda S, Yoshida H, Ogura K, et al. Assessment of gastric carcinoma risk associated with Helicobacter pylori may vary depending on the antigen used: CagA specific ELISA versus commercially available H. pylori ELISAs. Cancer 2000;88:1530-5.
51. Siman JH, Forsgren G, Berglund G, et al. Tobacco smoking and Helicobacter pylori infection are risk factors of gastric adenocarcinoma. Gut 1998;43(Suppl 2):A63.
52. Fox JG, Dangler CA, Taylor NS, et al. High-salt diet induces gastric epithelial hyperplasia and parietal cell loss, and enhances Helicobacter pylori colonization in C57BL/6 mice. Cancer Res 1999;59:4823-8.
53. Huntsman DG, Carneiro F, Lewis FR, et al. Early gastric cancer in young, asymptomatic carriers of germ-line e-cadherin mutations. N Engl J Med 2001;344:1904-9.
54. Fujimura Y, Inoue S, Lida M, et al. Synchronous multiple gastric cancers associated with familial gastric cancers. Gastrointest Endoscopy 2000;51:742-5.
55. Carneiro F, Taveira-Gomes A, Cabral-Correia A, et al. Characteristics of the gastric mucosa of direct relatives of patients with sporadic gastric carcinoma. Eur J Cancer Prev 1993;2:239-46.
56. El-Omar EM, Oien K, Murray LS, et al. Increased prevalence of precancerous changes in relatives of gastric cancer patients: critical role of H. pylori. Gastroenterology 2000;118:22-30.
57. 1 hybrid mice. Gut 1999;45:335-40.
58. Miehlke S, Genta RM, Graham DY, et al. Molecular relationships of Helicobacter pylori strains in a family with gastroduodenal disease. Am J Gastroenterol 1999;94:364-8.
59. Azuma T, Ito S, Sato F, et al. The role of the HLA-DQA1 gene in resistance to atrophic gastritis and gastric adenocarcinoma induced by Helicobacter pylori infection. Cancer 1998;82:1013-8.
60. Sakai T, Aoyama N, Satonaka K, et al. HLA-DQB1 locus and the development of atrophic gastritis with Helicobacter pylori infection. J Gastroenterol 1999;34(Suppl 11):24-7.
61. El-Omar E, Carrington M, Chow WH, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000;404:398-402.
62. Machado JC, Pharoah P, Sousa S, et al. Interleukin 1B and interleukin 1RN polymorphism are associated with increased risk of gastric carcinoma. Gastroenterology 2001;121:823-9.
63. El-Omar EM. The importance of interleukin 1β in Helicobacter pylori-associated disease. Gut 2001;48:743-7.
64. Fei G, Ridwelski K, Nawrin C, et al. Reduced PTEN expression in gastric cancer and in the mucosa of gastric cancer relatives [abstract]. Gastroenterology 2000;118:A58.
65. Ebert M, Yu J, Miehlke S, et al. Alpha-catenin expression is decreased in human gastric cancers and in the gastric mucosa of first-degree relatives [abstract]. Gastroenterology 2000;118:A42.
66. Grady WM, Guilford PJ, Willis J. et al. Inactivation of E-cadherin in stomach cancers arising in the hereditary diffuse gastric cancer syndrome [abstract]. Gastroenterology 2000;118:A665.
67. Saito A, Kanai Y, Maesawa C, et al. Disruption of E-cadherin-mediated cell adhesion systems in gastric cancers in young patients. Jpn J Cancer Res 1999;90:993-9.
68. Miehlke S, Yu J, Szokodi D, et al. Increased expression of cyclooxygenase-2 (COX-2) in gastric carcinoma and in the gastric mucosa of healthy first-degree relatives [abstract]. Gastroenterology 2000;118:A761.
69. Miehlke S, Szokodi D, Yu J, et al. Expression of cyclins in gastric carcinoma and in the gastric mucosa of first-degree relatives [abstract]. Gastroenterology 2000;118:A761.
70. Setiawan VW, Zhang ZF, Yu GP, et al. GSTT1 and GSTM1 null genotypes and the risk of gastric cancer: A case-control study in a Chinese population. Cancer Epidemiol Biomarkers Prev 2000;9:73-80.
71. Parsonnet J, Harris RA, Hack HM, et al. Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: A mandate for clinical trial. Lancet 1996;348:150-4.
72. Harris RA, Owens DK, Witherell H, et al. Helicobacter pylori and gastric cancer: what are the benefits of screening only for CagA phenotype of H. pylori? Helicobacter 1999;4:69-76.
73. Fendrick AM, Chernew ME, Hirth RA, et al. Clinical and economic effects of population-based Helicobacter pylori screening to prevent gastric cancer. Arch Intern Med 1999;159:142-8.
74. Sonnenberg A, Inadomi JM. Review article: Medical decision models of Helicobacter pylori therapy to prevent gastric cancer. Alim Pharmacol Ther 1998;12:111-21.